Stock listing

ATHEX:VIDAVO Vidavo SA Μετοχή

Follow Vidavo SA into a list and get an email when it puts out news.

Share price · ATHEX:VIDAVO

€8.55 EUR 0.00 (0.0%)

Close on Nov 19, 2026

Past year +52.7% · daily closes, Nov 19, 2025 – Nov 19, 2026, adjusted for splits
Day range
€8.55 – €8.55 EURNov 19, 2026
Market cap
€8.91M EURAt the close on Nov 19, 2026 · price × 1.04M shares outstanding
52-week range
€5.60 – €11.50 EURLowest and highest trades, Nov 20, 2025 – Nov 19, 2026
Traded on an average day
€4,714 EURMedian day 100 shares · 26 days with no trades · last 3 months, Aug 19, 2026 – Nov 19, 2026
Vidavo SA logo

Daily closes

Last 3 months, Aug 19, 2026 – Nov 19, 2026 · ATHEX:VIDAVO · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€8.550.000.0%€8.55€8.55€8.550
€8.550.000.0%€8.90€8.90€8.551
€8.550.000.0%€8.55€8.55€8.550
€8.55-0.40-4.5%€8.40€8.60€8.40600
€8.950.000.0%€8.95€8.95€8.950
€8.95+0.15+1.7%€8.80€8.95€8.55700
€8.80-0.20-2.2%€8.70€8.95€8.65935
€9.00-0.35-3.7%€8.90€9.00€8.456,925
€9.35-0.15-1.6%€9.10€9.60€9.10220
€9.50+0.20+2.2%€9.50€9.50€9.50100
€9.300.000.0%€9.30€9.30€9.300
€9.30-0.25-2.6%€9.30€9.45€9.20600
€9.55-0.25-2.6%€9.25€9.70€9.151,311
€9.80+0.30+3.2%€9.80€9.80€9.80100
€9.50-0.05-0.5%€9.20€9.55€9.10323
€9.550.000.0%€9.40€9.55€9.4011
€9.55-0.35-3.5%€10.00€10.00€9.551,550
€9.90-0.05-0.5%€9.55€9.90€9.55750
€9.950.000.0%€9.60€9.95€9.50900
€9.95-0.05-0.5%€9.70€10.00€9.70450
€10.000.000.0%€9.70€10.00€9.70550
€10.000.000.0%€10.00€10.00€10.000
€10.00-0.10-1.0%€9.60€10.00€9.502,578
€10.100.000.0%€10.10€10.10€10.100
€10.100.000.0%€10.10€10.10€10.100
€10.100.000.0%€10.10€10.10€10.100
€10.100.000.0%€10.10€10.10€10.100
€10.10+0.10+1.0%€10.00€10.10€10.00250
€10.00-0.10-1.0%€10.00€10.10€9.70250
€10.10-0.20-1.9%€9.70€10.20€9.65451
€10.300.000.0%€10.30€10.30€10.30250
€10.300.000.0%€10.30€10.30€10.300
€10.30-0.10-1.0%€9.90€10.30€9.90340
€10.40-0.10-1.0%€10.30€10.50€10.30250
€10.500.000.0%€10.50€10.50€10.500
€10.50+0.10+1.0%€10.50€10.50€9.75134
€10.40-0.20-1.9%€10.40€10.60€10.4035
€10.600.000.0%€10.60€10.60€10.600
€10.600.000.0%€10.60€10.60€10.600
€10.600.000.0%€10.60€10.60€10.50321
€10.60-0.10-0.9%€10.90€10.90€10.50124
€10.700.000.0%€10.70€10.70€10.700
€10.70-0.10-0.9%€11.50€11.50€10.60950
€10.800.000.0%€10.00€11.00€10.0035
€10.800.000.0%€10.80€10.80€10.800
€10.800.000.0%€10.80€10.80€10.800
€10.800.000.0%€10.80€10.80€10.800
€10.800.000.0%€10.80€10.80€10.800
€10.800.000.0%€10.80€10.80€10.800
€10.800.000.0%€10.80€10.80€10.800
€10.80+0.20+1.9%€10.10€10.80€10.001,835
€10.600.000.0%€10.60€10.60€10.600
€10.60+0.20+1.9%€10.00€10.60€9.654,634
€10.400.000.0%€10.40€10.40€10.401
€10.400.000.0%€10.40€10.40€10.400
€10.40+0.50+5.1%€10.40€10.40€10.400
€9.90-0.50-4.8%€9.90€10.40€9.901
€10.40-0.10-1.0%€10.60€10.60€9.85942
€10.500.000.0%€10.50€10.50€10.500
€10.500.000.0%€10.50€10.50€10.500
€10.50+0.10+1.0%€10.50€10.50€10.50102
€10.400.000.0%€10.40€10.40€10.400
€10.40-0.10-1.0%€10.40€10.40€10.40350
€10.50+0.10+1.0%€10.40€10.50€10.40800
€10.40+0.10+1.0%€10.40€10.40€10.40250
€10.30+0.10+1.0%€9.20€10.30€9.20700
Ticker
ATHEX:VIDAVO
Asset type
Stock
Sector
Health care
Industry
Health care services
Exchange
ATHEX
Currency
EUR

Vidavo SA on 6ix

Sector
Health care
Industry
Health care services
Decks
1 deck · latest April 2015

Valuation

P/E 15.0× against a median of 74.0×: 3rd lowest of 5 Health care services companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 19, 2026

Enterprise value
€7.51M EUR
P/E
15.0×
EV/sales
3.5×
EV/EBITDA
9.2×
Price/book
4.1×
Gross margin
55.2%
Operating margin
35.4%
Net margin
27.4%
Debt to equity
0.0×
Beta
No index for this market yet

Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Vidavo SA · ATHEX:VIDAVOUS$9.78MUS$8.25M15.0×3.5×9.2×4.1×27.4%0.0×n/a
Republic Healthcare Limited · HKEX:8357US$10.83MUS$9.29Mn/a1.2×n/a1.8×−40.3%0.4×n/a
Scandinavian Medical Solutions A/S · OMXCOP:SMSMEDUS$10.61MUS$21.25M2,780×0.6×13.9×1.0×0.0%1.0×n/a
Medilines Distributors, Inc. · PSE:MEDICUS$10.33MUS$9.37Mn/an/an/a0.3×n/a0.0×n/a
KT Medical Service Public Company Limited · SET:KTMSUS$10.25MUS$8.24M9.6×0.4×2.8×0.6×5.1%0.0×n/a
Morefield Group N.V. · EURONEXT:MOREUS$10.12MUS$75.51M2.2×0.4×2.6×0.4×2.6%3.1×n/a
Concord Medical Services Holdings Ltd. · NYSE:CCMUS$9.99MUS$509.8Mn/a7.4×n/an/a−20.2%n/a0.49
AIML Innovations Inc · CSE:AIMLUS$9.68MUS$11.23Mn/a369×n/an/an/an/a0.33
UCrest Bhd · MYX:UCRESTUS$9.05MUS$6.78M138×2.0×34.7×0.9×1.9%0.0×n/a
HeartSciences Inc. · NASDAQ:HSCSUS$8.99MUS$8.96Mn/a1,984×n/an/an/an/a1.23
PainChek Ltd · ASX:PCKUS$8.86MUS$7.71Mn/a3.1×n/an/a−238.8%n/an/a
Median of the othersUS$10.06MUS$9.33M74.0×2.0×8.4×0.8×0.0%0.2×0.49

Team and board

OfficerRole
Pantelis AngelidisFounder

Decks

DeckKindSlidesDate
Investor Presentation (April 2015)Investor deck8 slidesApril 2015

Open Decks

Financials

Annual, in EUR

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue2.16M1.10M697.2K638.4K374.9K311.9K280.4K
Cost of revenue967.8K729.1K186.7K226.2K59.2K34.8K47.1K
Gross profit1.19M366.5K510.5K412.2K315.7K277.1K233.3K
Research and development297.2K251.9K677.1K928.7K737.0K434.4K336.9K
Selling, general and administrative55.1K103.6K133.3K126.0K84.9K54.8K61.6K
Operating income765.4K-18.9K154.4K-35.4K113.4K111.3K96.5K
Depreciation and amortization55.3K30.3K34.4K22.6K18.5K13.5K13.1K
EBITDA820.8K11.4K188.8K-12.8K132.0K124.7K109.6K
Interest expense7.61K4.79K11.7K3.17K3.58K3.31K3.40K
Income before tax757.8K-27.6K142.7K-93.2K102.8K98.2K104.3K
Net income593.1K-30.4K123.9K-100.8K59.8K92.6K101.9K
Earnings per share, basic0.57-0.030.13-0.120.070.110.12

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents738.4K182.8K206.7K81.3K99.7K329.5K97.1K
Receivables1.10M95.9K86.2K109.1K114.1K123.9K136.0K
Inventory63.9K42.1K35.5K30.8K52.9K40.7K34.2K
Current assets2.21M645.6K1.11M1.22M1.56M1.28M1.39M
Total assets2.85M1.19M1.46M1.53M1.87M1.55M1.72M
Accounts payable535.4K97.4K116.4K137.0K9022851.97K
Current liabilities851.6K286.3K509.1K676.4K918.6K745.9K962.8K
Total liabilities1.04M448.2K693.0K887.4K1.13M864.3K1.13M
Shareholders' equity1.81M736.9K763.4K639.6K742.7K683.3K591.8K
Shares outstanding1.05M933.9K932.9K856.3K856.5K856.9K857.1K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations180.9K212.2K238.7K-15.0K-206.2K234.3K-108.5K
Capital spending-207.4K-240.0K-94.1K-7.91K-23.2K-1.01K-77.4K
Free cash flow-26.4K-27.8K144.5K-22.9K-229.4K233.3K-185.9K
Share buybacks-165-2.25K-396-1.10K0
Change in cash555.7K-23.9K125.4K-18.4K-229.8K232.3K-185.4K

Open Financials

Cap table

Built by 6ix from Vidavo SA’s releases

Common shares
1,041,998
Fully diluted
1,041,998

Fully diluted

LineShares
Common shares1,041,998

Share count over time

CountShares
Nov 22, 20261,041,998

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Pantelis AngelidisFounder · Since at least Nov 4, 2026

Open People

Log in to ask 6ix AI your own questions about Vidavo SA.